Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
about
Differentiation and transdifferentiation potentials of cancer stem cellsIn vitro human cell line models to predict clinical response to anticancer drugsMetabolic control of cancer cell stemness: Lessons from iPS cellsThe nutritional phenome of EMT-induced cancer stem-like cellsCancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Metabostemness: a new cancer hallmark.Oncometabolic Nuclear Reprogramming of Cancer Stemness.
P2860
Q26782242-5FD15F74-D9E9-43CE-9406-1888D9FF9EA7Q27000665-0F9FDC06-D949-47DB-9CAA-DA571AF92759Q28081608-CB40D2FF-6F9B-4303-8C81-B0978DBF5633Q34100815-6CD07895-C8CA-4A75-BE87-0AC59357DA65Q36544839-52595D8E-A704-44B5-A378-3CF23B555980Q38261030-02EBA204-9BA2-40D6-B22C-7C66B9D07068Q38951334-842925EB-EA70-4A54-9211-D1320AEBAFF8
P2860
Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Xenopatients 2.0: reprogrammin ...... atient-derived cancer genomes.
@en
type
label
Xenopatients 2.0: reprogrammin ...... atient-derived cancer genomes.
@en
prefLabel
Xenopatients 2.0: reprogrammin ...... atient-derived cancer genomes.
@en
P2093
P2860
P50
P356
P1433
P1476
Xenopatients 2.0: reprogrammin ...... atient-derived cancer genomes.
@en
P2093
Bruna Corominas-Faja
Eugeni López-Bonet
Luciano Vellon
Tomás Alarcón
P2860
P304
P356
10.4161/CC.27770
P577
2014-01-09T00:00:00Z